Celldex Statistics
Want to see CLDX full AI Analyst Report?
Celldex (CLDX) Stock Statistics & Valuation Metrics
Total Valuation
Celldex has a market cap or net worth of $2.26B. The enterprise value is $1.91B.
- Market Cap
- $2.26B
- Enterprise Value
- $1.91B
Share Statistics
Celldex has 78,545,050 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 78,545,050
- Owned by Insiders
- 0.30%
- Owned by Institutions
- 64.76%
Financial Efficiency
Celldex’s return on equity (ROE) is -0.49 and return on invested capital (ROIC) is -53.87%.
- Return on Equity (ROE)
- -0.49
- Return on Assets (ROA)
- -0.44
- Return on Invested Capital (ROIC)
- -53.87%
- Return on Capital Employed (ROCE)
- -0.54
- Revenue Per Employee
- 7,575.758
- Profits Per Employee
- -1.31M
- Employee Count
- 198
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Celldex is -6.69. Celldex’s PEG ratio is 0.28.
- PE Ratio
- -6.69
- PS Ratio
- 20218.34
- PB Ratio
- 3.49
- Price to FCF
- -8.73
- Price to Operating Cash Flow
- -8.99
- PEG Ratio
- 0.28
Income Statement
In the last 12 months, Celldex had revenue of 1.50M and earned -258.80M in profits. Earnings per share was -3.90.
- Revenue
- 1.50M
- Gross Profit
- 1.50M
- Operating Income
- -287.40M
- Pretax Income
- -258.80M
- Net Income
- -258.80M
- EBITDA
- -255.42M
- Earnings Per Share (EPS)
- -3.90
Cash Flow
In the last 12 months, operating cash flow was -251.97M and capital expenditures -7.48M, giving a free cash flow of -259.45M billion.
- Operating Cash Flow
- -251.97M
- Free Cash Flow
- -259.45M
- Free Cash Flow per Share
- -3.30
Dividends & Yields
Celldex pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -11.46%
- Earnings Yield
- -13.65%
Stock Price Statistics
- Beta
- 1.39
- 52-Week Price Change
- 21.54%
- 50-Day Moving Average
- 32.20
- 200-Day Moving Average
- 32.98
- Relative Strength Index (RSI)
- 43.46
- Average Volume (3m)
- 1.34M
Important Dates
Celldex upcoming earnings date is Mar 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Mar 01, 2027
- Ex-Dividend Date
- ―
Financial Position
Celldex as a current ratio of 10.49, with Debt / Equity ratio of 0.44%
- Current Ratio
- 10.49
- Quick Ratio
- 10.49
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.10
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Celldex has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Celldex EV to EBITDA ratio is -7.36, with an EV/FCF ratio of -8.66.
- EV to Sales
- 20065.82
- EV to EBITDA
- -7.36
- EV to Free Cash Flow
- -8.66
- EV to Operating Cash Flow
- -8.92
Balance Sheet
Celldex has $650.32M in cash and marketable securities with $9.87M in debt, giving a net cash position of $640.45M billion.
- Cash & Marketable Securities
- $650.32M
- Total Debt
- $9.87M
- Net Cash
- $640.45M
- Net Cash Per Share
- $8.15
- Tangible Book Value Per Share
- $7.92
Margins
Gross margin is -662.50%, with operating margin of -298657.14%, and net profit margin of -275986.61%.
- Gross Margin
- -662.50%
- Operating Margin
- -298657.14%
- Pretax Margin
- -275986.61%
- Net Profit Margin
- -275986.61%
- EBITDA Margin
- -272652.68%
- EBIT Margin
- -275986.61%
Analyst Forecast
The average price target for Celldex is $67.18, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $67.18
- Price Target Upside
- 133.03% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 11
- Revenue Growth Forecast
- -93.92%
- EPS Growth Forecast
- -27.48%
Scores
- Smart Score
- 4
- AI Score
- 57
